22-7-2019 09:21:49

Novartis Hold

Samenvatting: Novartis AG Hold
Bedrijf:
Novartis AG
Analist:
HSBC
Koersdoel:
88 CHF
Huidige Rating:
Hold
Koers*:
92,0100021362305 CHF
Afstand tot Koersdoel*:
-4,35822415294944%
Rating update:
Hold
Laatste koers:
86,26 CHF
Afstand Koersdoel:
2,01715743102249%
Analist naam::
Stephen McGarry
K/W-verhouding*:
-
* Zum Zeitpunkt der Analyse
Meer nieuws

Analisten over Novartis AG

17-9-2019 Novartis Goldman Sachs Group Inc.
16-9-2019 Novartis Hold Deutsche Bank AG
13-9-2019 Novartis Goldman Sachs Group Inc.
13-9-2019 Novartis Buy Merrill Lynch & Co., Inc.
10-9-2019 Novartis Neutral UBS AG
meer analisten

Invoer toevoegen

Aandelen in dit artikel

Novartis AG 86,26 0,44% Novartis AG

Laatste Analisten adviezen

20-9-2019 Apple Neutral Credit Suisse Group
20-9-2019 Novo Nordisk Overweight JP Morgan Chase & Co.
20-9-2019 WACKER CHEMIE Neutral JP Morgan Chase & Co.
20-9-2019 Zurich Insurance Buy Goldman Sachs Group Inc.
20-9-2019 Assicurazioni Generali Neutral Goldman Sachs Group Inc.
20-9-2019 AXA Goldman Sachs Group Inc.
20-9-2019 Allianz Neutral Goldman Sachs Group Inc.
20-9-2019 Vodafone Group Buy HSBC
20-9-2019 Commerzbank RBC Capital Markets
20-9-2019 Intesa Sanpaolo Buy HSBC
20-9-2019 UniCredit Buy HSBC
20-9-2019 Deutsche Telekom Buy HSBC
20-9-2019 Airbus Buy Kepler Cheuvreux
20-9-2019 Eni Buy Kepler Cheuvreux
20-9-2019 ProSiebenSat1 Media Neutral Oddo BHF
20-9-2019 RTL Buy Oddo BHF
20-9-2019 Wirecard Buy Kepler Cheuvreux
20-9-2019 BAUER Hold Kepler Cheuvreux
20-9-2019 GlaxoSmithKline Neutral JP Morgan Chase & Co.
20-9-2019 AstraZeneca Overweight JP Morgan Chase & Co.
20-9-2019 Diageo Hold Independent Research GmbH
20-9-2019 Société Générale (Societe Generale Hold Independent Research GmbH
20-9-2019 Novo Nordisk Hold Independent Research GmbH
20-9-2019 Givaudan Buy Merrill Lynch & Co., Inc.
20-9-2019 Air Liquide Buy Merrill Lynch & Co., Inc.
20-9-2019 Akzo Nobel Underperform Merrill Lynch & Co., Inc.
20-9-2019 LANXESS Buy Merrill Lynch & Co., Inc.
20-9-2019 Symrise Buy Merrill Lynch & Co., Inc.
20-9-2019 FUCHS PETROLUB Underperform Merrill Lynch & Co., Inc.
20-9-2019 Evonik Underperform Merrill Lynch & Co., Inc.
20-9-2019 BASF Underperform Merrill Lynch & Co., Inc.
20-9-2019 Shell (Royal Dutch Shell) (A Outperform Credit Suisse Group
20-9-2019 TOTAL Outperform Credit Suisse Group
20-9-2019 Knorr-Bremse Underperform Credit Suisse Group
20-9-2019 Rolls-Royce Goldman Sachs Group Inc.
20-9-2019 RWE Goldman Sachs Group Inc.
20-9-2019 BNP Paribas Buy UBS AG
20-9-2019 Société Générale (Societe Generale Buy UBS AG
20-9-2019 RWE Buy UBS AG
20-9-2019 EON Neutral UBS AG
20-9-2019 Knorr-Bremse Buy UBS AG
20-9-2019 TRATON Buy UBS AG
20-9-2019 Peugeot Neutral UBS AG
20-9-2019 CompuGroup Medical Hold Warburg Research
20-9-2019 BAUER Hold Warburg Research
20-9-2019 AB InBev SA-NV (Anheuser-Busch InBev Outperform Bernstein Research
20-9-2019 AB InBev SA-NV (Anheuser-Busch InBev Neutral UBS AG
20-9-2019 Eni Outperform Bernstein Research
20-9-2019 Novo Nordisk Underperform Jefferies & Company Inc.
20-9-2019 Unilever Underweight Barclays Capital